BIVSX — Balter Invenomic Fund
Data updated: 2026-06-26
BIVSX — Balter Invenomic Fund data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Small Cap Value Equity · $970.08M AUM · 2.80% expense ratio · 0.0% 1-yr return. From SEC regulatory filings.
BIVSX Fund Overview
BIVSX — Balter Invenomic Fund is a US mutual fund managed by Northern Lights Fund Trust II, categorised as United States Small Cap Value Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Northern Lights Fund Trust II
- Category: United States Small Cap Value Equity
- Assets under management: $970.08M
- 1-year return: 0.0%
- Ticker: BIVSX
- SEC CIK: 0001518042
- SEC series ID: S000057713
- Share class ID: C000211283
BIVSX Holdings
Top 10 holdings of Balter Invenomic Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| First American Funds, Inc. | 7.12% |
| Lyft, Inc. | 3.15% |
| Workday, Inc. | 3.11% |
| Fiserv, Inc. | 3.06% |
| Salesforce, Inc. | 3.01% |
| Global Payments, Inc. | 2.88% |
| Fidelity National Information Services, Inc. | 2.33% |
| Ingredion, Inc. | 2.10% |
| Dentsply Sirona, Inc. | 2.09% |
| Penn Entertainment, Inc. | 2.01% |
BIVSX Portfolio Allocation
Asset-class allocation of Balter Invenomic Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 114.5% |
| Cash & Equivalents | 7.1% |
BIVSX Performance
Total returns for BIVSX (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -6.4% |
| 1 year | 0.0% |
| 3 years (annualised) | -2.8% |
| 5 years (annualised) | 13.4% |
BIVSX Risk Information
Risk metrics for BIVSX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 21.0%
BIVSX Costs and Fees
BIVSX costs about $280 per $10,000 invested per year in fund expenses.
- Net expense ratio: 2.80%
- Gross expense ratio: 2.82%
- Portfolio turnover: 197%
- Brokerage commissions: 43.82 bps of average net assets (SEC N-CEN)
BIVSX Cashflows
Over the 12 months to 2026-04, Balter Invenomic Fund had net outflows of $65.08M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-04 | −$12.47M |
| 2026-03 | $16.45M |
| 2026-02 | $13.01M |
| 2026-01 | −$50.42M |
| 2025-12 | $40.06M |
| 2025-11 | −$4.62M |
BIVSX Debt Constituents
No individual debt constituents are reported in Balter Invenomic Fund's latest SEC N-PORT filing.
BIVSX Prospectus and SEC Filings
Official Balter Invenomic Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Small Cap Value Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.